DiTEBA publishes new IVRT/IVPT E-Book to assist industry with new drug submissions

May 25, 2016

As the topical and transdermal drug market continues to grow, the FDA is increasingly emphasizing the use of In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) for new submissions.

Do you know what is required to ensure FDA/regulatory compliance for your submission?

Download our comprehensive IVRT/IVPT E-Book to gain an in-depth knowledge of this increasingly required, but often challenging, testing method for topical and semisolid drugs.


Back to News